An updated systematic review and meta-analysis: correlation between circulating plasminogen activator inhibitor-1 levels and metabolic dysfunction-associated steatotic liver disease

An updated systematic review and meta-analysis: correlation between circulating plasminogen activator inhibitor-1 levels and metabolic dysfunction-associated steatotic liver disease

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD)—formerly known as non-alcoholic fatty liver disease—is the leading cause of chronic liver disease globally. However, early diagnosis and specific treatment have not yet been achieved. Plasminogen activator inhibitor...

Full description

Saved in:
Bibliographic Details
Main Authors: Qicong Li, Yuting Ruan, Yuqing Zhu, Yingying Cai, Kaihan Wu, Chenglu Shen, Qin Zhang, Shuaihang Chen, Jie Hu, Shan Liu, Miaojuan Wang
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Gastroenterology
Subjects:
Metabolic dysfunction-associated steatotic liver disease
Non-alcoholic fatty liver disease
Plasminogen activator inhibitor-1
Meta-analysis
Online Access:https://doi.org/10.1186/s12876-025-04148-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12876-025-04148-8

Similar Items